Musculoskeletal Cancer
Overview
The Max Institute of Cancer Care’s Musculoskeletal / Orthopaedic Oncology Disease Management Group (DMG) is a committed team of specialists whose goal is to treat all patients who present with benign and malignant tumors of the bones and soft tissues with comprehensive management. It is now beyond question that multidisciplinary involvement is necessary for the management of these rare diseases to succeed optimally, and we at the Max Institute of Cancer Care (MICC) are proud to have a team of skilled physicians with a focus on treating patients with bone and soft tissue tumors. The members of this team include molecular oncologists, pathologists, radiologists, onco-psychologists, nuclear medicine specialists, and orthopaedic, surgical, medical, and radiation oncologists.
Every patient with musculoskeletal cancer requires specific planning and customization of their care. All of these cases are handled by a multidisciplinary tumor board at the Max Institute of Cancer Care, where experts from the fields of orthopaedic oncology, surgical oncology, radiation oncology, medical oncology, radiology, and pathology thoroughly discuss each case to develop a treatment plan that not only maximizes survival but also ensures positive functional outcomes.
WHY WE DO IT.
Surgery for cancer:
All bone and soft tissue tumors, both malignant and benign, are managed surgically.
- The use of prostheses, bone transplants, extracorporeal radiation therapy (ECRT), cryosurgery, and other techniques are used in limb salvage surgery for malignant bone tumours (osteosarcoma, Ewing sarcoma, chondrosarcoma, and others).
- Modern imaging techniques are used for precise bone tumor treatment, guaranteeing total tumor removal and maximizing form and function.
- Surgery to save limbs from soft tissue sarcomas
- Treatment for benign bone tumors (chondroblastoma, osteoblastoma, giant cell tumors, etc.)
- benign bone tumors may be treated non-surgically with sclerotherapy and radiofrequency ablation. (Osteoid osteoma, simple bone cysts, aneurysmal bone cysts, etc.)
- Treatment for metastatic bone disease, or bone involvement brought on by cancer cells spreading from other organs such the lung, breast, prostate, etc. Adjuvant fixations for therapeutic and preventative purposes aid in achieving early mobilization.
- Decompression and stabilization are used to treat spine tumors, whether they are primary or metastatic. It is possible to perform minimally invasive procedures like vertebroplasty and balloon kyphoplasty.
Medical Oncology: Current treatments for bone and soft tissue sarcomas with chemotherapy are widely approved. - knowledge of both adjuvants and neoadjuvants Adult and pediatric bone and soft tissue sarcomas treated with chemotherapy
- Advanced stage diseases: palliative chemotherapy or targeted therapy
- where necessary, high-dose chemotherapy combined with stem cell transplantation
- Children with sarcomas get only chemotherapy at a dedicated pediatric oncology facility.
- prioritize optimizing survival while maintaining organ and function
- For the best possible diagnosis and treatment, expert pathology and radiology inputs are combined with clinical correlation through Ortho-Radio Patho
- a commitment to providing individualized, evidence-based care with a focus on patient-specific solutions
Musculoskeletal tumor board and DMG (Disease Management Group) clinic meetings are held weekly. - For cancers of the bone and soft tissues, radiation therapy is used in radiation oncology.
- For both bone and soft tissue sarcomas, radiation therapy is administered definitively, prior to surgery, intraoperatively, intraoperatively, and postoperatively as needed for a particular instance.
- We use high dose precision radiation therapy (with high doses) with or without surgery depending on the reason for bone malignancies like Ewing’s sarcoma.
Interstitial brachytherapy during surgery: We use interstitial brachytherapy with brachytherapy catheter placement in tumour bed at the time of surgery and treatment in the early postoperative period as much as possible for soft tissue sarcomas. It avoids long-term radiation therapy following surgery and delivers high radiation therapy doses with fewer side effects.
Extracorporeal Radiation Therapy (ECRT): For some limb tumors, it is possible to surgically remove the affected bone, remove it from the patient’s body, and then provide a single high-dose radiation dosage to the bone. The patient’s body is subsequently provided with this bone. Extracorporeal radiation treatment is what this is known as. The goal of this high dose radiation is to destroy all tumor cells and healthy bone cells so that the patient can use this bone section as a personalized prosthetic. Radiation therapy has no effect on the patient because it is administered to bone that is not within the body. - Radiation therapy before surgery
- When preoperative radiation therapy is indicated for a soft tissue tumor or a bone tumor, we also use it instead of postoperative radiation therapy in an effort to reduce the long-term negative effects of postoperative radiation therapy and shrink the tumor.
radiation treatment with accuracy - At the Max Institute of Cancer Care (MICC), radiation therapy is administered using specialized methods such as intensity-modulated radiation therapy (3DCRT), image-guided radiation therapy (IGRT), and more. These methods assist us in greatly reducing both the acute and long-term side effects of treatment.
- We use stereotactic body radiation therapy (SBRT), which deposits a high radiation dosage with a low dose to the surrounding organs, to treat metastases from bone and soft tissue sarcomas.
